Endovascular treatment of primary hepatic tumours
Ch. Bachvarov, G. Todorov, N. Kolev, A. Tonev, V. Ignatov, K. Ivanov, I. Donev, S. Sirakov, G. Valchev
Primary hepatocellular cancer (HCC), in 80% of cases, is a complication of cirrhosis and is the fifth most common cancer in the world and the third cause of cancer mortality, representing 85-90% of malignant liver lesions. The most frequently used image-guided intraarterial liver tumor therapies performed by interventional radiologists include transarterial embolization (TAE), transarterial chemoembolization (TACE) with or without drug-eluting beads (DEBs) and radioembolization using Yttrium-90. Transarterial chemoembolization (TACE) is first applied by Yamada and others in 1977. TACE is the selective injection of chemotherapeutic agents and superselectivе embolization of the primary tumor feeding artery.
Key words:TRANSARTERIAL EMBOLIZATION.TRANSARTERIAL CHEMOEMBOLIZATION. RADIOEMBOLIZATION USING YTTRIUM-90